title: Use of polyethylene glycol in functional constipation and fecal impaction.
abstract: OBJECTIVE
  The objective of this study was to evaluate in an analytical and descriptive manner the evidence published so far on the use of polyethylene glycol (PEG), with or without electrolytes, in the management of functional constipation and the treatment of fecal impaction.
  
  
  METHODS
  Search on MEDLINE, EMBASE and Cochrane databases until May 2016 of all publications adjusted to the following terms: constipation AND/OR fecal impaction AND (PEG OR polyethylene glycol OR macrogol OR movicol OR idralax OR miralax OR transipeg OR forlax OR golytely OR isocolan OR mulytely) NOT colonoscopy. Critical reading of selected articles (English or Spanish), sorting their description according to group age (adult/pediatric age) and within those, in accordance with study features (efficacy evaluation versus placebo, doses query, safety, comparison with other laxatives, observational studies and monographic review articles of polyethylene glycol or meta-analysis).
  
  
  RESULTS
  Fifty-eight publications have been chosen for descriptive analysis; of them, 41 are clinical trials, eight are observational studies and nine are systematic reviews or meta-analysis. Twelve clinical trials evaluate PEG efficacy versus placebo, eight versus lactulose, six are dose studies, five compare polyethylene glycol with and without electrolytes, two compare its efficacy with respect to milk of magnesia, and the rest of the trials evaluate polyethylene glycol with enemas (two), psyllium (one), tegaserod (one), prucalopride (one), paraffin oil (one), fiber combinations (one) and Descurainia sophia (one).
  
  
  CONCLUSIONS
  Polyethylene glycol with or without electrolytes is more efficacious than placebo for the treatment of functional constipation, either in adults or in pediatric patients, with great safety and tolerability. These preparations constitute the most efficacious osmotic laxatives (more than lactulose) and are the first-line treatment for functional constipation in the short and long-term. They are as efficacious as enemas in fecal impaction, avoid the need for hospital admission and are well tolerated by patients (mainly when administered without electrolytes).
authors.affiliation: Servicio de Medicina Digestiva, Hospital Clínico de Valencia.
authors.forename: Miguel
authors.initials: M
authors.lastname: Mínguez
authors.affiliation: Hospital General Universitario Morales Meseguer.
authors.forename: Antonio
authors.initials: A
authors.lastname: López Higueras
authors.affiliation: Gestión del Conocimiento, SEPD, España.
authors.forename: Javier
authors.initials: J
authors.lastname: Júdez
mesh_terms: D000328:Adult; D002648:Child; D003248:Constipation / Q000188:drug therapy*; D005244:Fecal Impaction / Q000188:drug therapy*; D006801:Humans; D054368:Laxatives / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000627:therapeutic use*
chemical_list: D054368:Laxatives; D011092:Polyethylene Glycols